Mesoblast Limited
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-102.1M | $-88.0M | $-81.9M | $-91.3M | $-98.8M | $-77.9M | $-89.8M | $-35.3M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $303.0K | $402.0K | $953.0K | $1.1M | $1.0M | $585.0K | $562.0K | $909.0K |
| Amortization | $4.0M | $1.5M | $1.5M | $1.5M | $1.6M | $1.6M | $1.6M | $1.7M |
| Stock-Based Compensation | $9.2M | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-50.0M | $-48.5M | $-63.3M | $-65.8M | $-100.7M | $-50.4M | $-57.8M | $-75.0M |
| Investing Activities | ||||||||
| Capital Expenditures | $680.0K | $271.0K | $264.0K | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $120.0K | $-97.0K | $-194.0K | $-232.0K | $-1.6M | $-3.3M | $-1.0M | $-1.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $147.3M | $40.3M | $74.5M | $-9.9M | $108.5M | $131.1M | $71.6M | $68.6M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-50.6M | $-48.7M | $-63.5M | — | — | — | — | — |